| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |